TEL AVIV-YAFO, Israel — A hospital in Israel is predicting patients’ risk of suffering pulmonary embolism (PE) — a potentially life-threatening lung blockage and the third most common cause of death ...

Multi-center, multi-national study builds on existing U.S. PE Clearance and CE Mark to assess mechanical thrombectomy treatment and long-term functional outcomes in intermediate-risk PE patients ...

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

This clearance expands the use of Symphony – previously for the treatment of venous thrombosis – to now include PE, providing a comprehensive solution to effectively and efficiently treat the full ...